Phase II study of concurrent radiotherapy and chemotherapy for unresectable stage III non-small-cell lung cancer. Southern Osaka Lung Cancer Study Group. - Concepedia

Concepedia

Publication | Closed Access

Phase II study of concurrent radiotherapy and chemotherapy for unresectable stage III non-small-cell lung cancer. Southern Osaka Lung Cancer Study Group.

61

Citations

11

References

1995

Year

Kiyoyuki Furuse, Kaoru Kubota, Mutsuto Kawahara, Nobuhiro Kodama, Mitsumasa Ogawara, Masanori Akira, Shigemi Nakajima, M Takada, Y Kusunoki, Shunichi Negoro

Journal of Clinical Oncology

Abstract

Concurrent radiotherapy plus chemotherapy with mitomycin, vindesine, and cisplatin (MVP) can be safely administered to patients with stage III NSCLC, with excellent response rates and 2-year survival rates.

References

	Year	Citations

Page 1